See Why These Healthcare Stocks are Today’s Highlights: AGN, MNK, SUPN, and DPLO

NEW YORK, NY / ACCESSWIRE / February 26, 2016 / Market volatility and fluctuating healthcare spending levels across the globe continue to propel many investors to take the cautionary path when trading the Generics Drugs sphere. We at ValuableInvestment.com have a different philosophy to share: we see opportunities in select names in areas where many would be on the side line or exiting their position that could eventually lead to huge gains. Learn how you can apply our knowledge to your advantage by signing up for our free alerts at:

http://valuableinvestment.com/dailytradealerts

ValuableInvestment.com believes that there is always a way for investors to generate profit even when certain industries look like that little puppy you wanted to buy as a kid but still remember its puppy eyes as you walked away from the shelter. This is what we believe, with the right timing and disciplined technique, anyone in our investor community can become a pro in no time. We are not boasting; it is the thousands of members who have seem huge gains over and over trading our strategies that give us the confidence to say so. Learn how the pros do it by clicking the link below:

http://valuableinvestment.com

Today’s pre-market research directs our attention on the following Healthcare stocks: Allergan PLC (NYSE: AGN), Mallinckrodt PLC (NYSE: MNK), Supernus Pharmaceuticals Inc. (NASDAQ: SUPN) and Diplomat Pharmacy Inc. (NYSE: DPLO). Check out the full story on these names and also get introduced to The Biotech pick for this quarter at:

http://valuableinvestment.com/real-story

On Thursday, shares in Allergan PLC ended the session 4.09% higher at $296.34. The stock recorded a trading volume of 3.86 million shares, which was above its three months average volume of 2.85 million shares. The Company’s shares have advanced 0.59% in the last month. The Company is trading 0.85% above its 50-day moving average. Moreover, shares of Allergan have a Relative Strength Index (RSI) of 58.25. Sign up and read the alert on AGN at:

http://valuableinvestment.com/AGN

Mallinckrodt PLC’s stock surged 1.60%, to close the day at $67.32. The stock recorded a trading volume of 1.21 million shares. The Company’s shares have advanced 4.68% in the last one month and 1.85% over the previous three months. The Company is trading 0.13% below its 50-day moving average. Additionally, Mallinckrodt has an RSI of 52.47. The complimentary trade alert on MNK can be turned on at:

http://valuableinvestment.com/MNK

On Thursday, shares in Supernus Pharmaceuticals Inc. recorded a trading volume of 515,241 shares. The Company’s stock ended the day 2.51% lower at $13.19. The stock has advanced 12.26% in the last one month. The Company is trading above its 50-day moving average by 5.11%. Furthermore, shares of Supernus Pharmaceuticals have an RSI of 54.10. Register for free on ValuableInvestment.com and access key information on SUPN at:

http://valuableinvestment.com/SUPN

Diplomat Pharmacy Inc.’s stock finished yesterday’s session 0.61% lower at $34.11 with a total of 481,197 shares traded. The stock has advanced 7.37% in the last one month. The Company’s shares are trading above their 50-day moving average by 9.12%. Furthermore, Diplomat Pharmacy’s stock has an RSI of 64.30. DPLO alerts are available for free at:

http://valuableinvestment.com/DPLO

—

About ValuableInvestment.com:

Valuable Investment was founded in 2006 and has been successfully alerting investors and shareholders of the most profitable ways to earn a living on Wall Street. A decade is a very long time so we must be doing something right. We encourage everyone to come and try our strategy and see how we have been changing the foundation of research for years.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY

ValuableInvestment.com, the Author, the Reviewer, and the Sponsor (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither valuableinvestment.com nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To read our disclosures, or for more information, visit http://valuableinvestment.com/

RESTRICTIONS

ValuableInvestment.com is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press@valuableinvestment.com

SOURCE: ValuableInvestment.com

ReleaseID: 437221